ORKAMBI IN PATIENTS WITH CYSTIC FIBROSIS AND SEVERE LIVER DISEASE

被引：0
|
作者：
Lim, A. [1 ]
Balouch, F. [2 ]
Cheney, J. [1 ]
Lewindon, P. [2 ]
Roberts, J. [3 ]
Schneider [4 ]
Shevill [1 ]
Wainwright, C. [1 ]
机构：
[1] Queensland Childrens Hosp, Dept Resp & Sleep Med, South Brisbane, Qld, Australia
[2] Queensland Childrens Hosp, Dept Gastroenterol, South Brisbane, Qld, Australia
[3] Royal Brisbane & Womens Hosp, Dept Pharmacol, Herston, Qld, Australia
[4] Univ Melbourne, Dept Pharmacol & Therapeut, Melbourne, Vic, Australia
来源：
RESPIROLOGY | 2020年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
TP 092
引用
收藏
页码：156 / 156
页数：1
相关论文
共 50 条
  • [1] ORKAMBI IN PATIENTS WITH CYSTIC FIBROSIS AND SEVERE LIVER DISEASE
    Lim, A.
    Balouch, F.
    Cheney, J.
    Lewindon, P.
    Roberts, J.
    Schneider, E.
    Shevill, E.
    Wainwright, C.
    RESPIROLOGY, 2021, 26 : 156 - 156
  • [2] PHENOTYPIC CHARACTERISTICS OF CYSTIC FIBROSIS PATIENTS WITH SEVERE LIVER DISEASE
    Stonebraker, J. R.
    Ooi, C. Y.
    Pace, R. G.
    Corvol, H.
    Knowles, M. R.
    Durie, P. R.
    Ling, S. C.
    PEDIATRIC PULMONOLOGY, 2014, 49 : 412 - 412
  • [3] LIVER TESTS IN F508DEL HOMOZYGOUS CYSTIC FIBROSIS PATIENTS ON ORKAMBI
    Paluck, Felicia
    Linnane, Barry
    ARCHIVES OF DISEASE IN CHILDHOOD, 2019, 104 : A144 - A145
  • [4] Lumacaftor/Ivacaftor (Orkambi) for Cystic Fibrosis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1491): : 41 - 42
  • [5] Features of Severe Liver Disease With Portal Hypertension in Patients With Cystic Fibrosis
    Stonebraker, Jaclyn R.
    Ooi, Chee Y.
    Pace, Rhonda G.
    Corvol, Harriet
    Knowles, Michael R.
    Durie, Peter R.
    Ling, Simon C.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (08) : 1207 - +
  • [6] Liver disease in patients with cystic fibrosis
    Kamal, Natasha
    Surana, Pallavi
    Koh, Christopher
    CURRENT OPINION IN GASTROENTEROLOGY, 2018, 34 (03) : 146 - 151
  • [7] INITIATIVE TO EDUCATE CYSTIC FIBROSIS PATIENTS ON THE PROPER ADMINISTRATION OF ORKAMBI
    Fulton, J.
    Hammond, J.
    Lingard, C.
    Gallo, K.
    Zemanick, E. T.
    Wagner, B.
    Sagel, S.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S455 - S456
  • [8] EARLY EXPERIENCE INITIATING ORKAMBI® THERAPY IN ADULT CYSTIC FIBROSIS PATIENTS
    Indihar, M., V
    Joseph, P.
    Trapnell, B.
    Burns, L. A.
    Meyers, M.
    Major, T.
    Montag, K.
    PEDIATRIC PULMONOLOGY, 2016, 51 : 300 - 300
  • [9] Outcome in patients with cystic fibrosis liver disease
    Rowland, Marion
    Gallagher, Cliona
    Gallagher, Charles G.
    Laoide, Risteard O.
    Canny, Gerard
    Broderick, Anne Marie
    Drummond, Jennifer
    Greally, Peter
    Slattery, Dubhfeasa
    Daly, Leslie
    McElvaney, Noel G.
    Bourke, Billy
    JOURNAL OF CYSTIC FIBROSIS, 2015, 14 (01) : 120 - 126
  • [10] Severe liver dysfunction in an infant with cystic fibrosis a masquerading as metabolic liver disease
    Srikanth, K. P.
    Panigrahi, Inusha
    Thapa, Babu Ram
    Vaiphei, Kim
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2016, 59 (03) : 339 - 347
12345